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ABSTRACT
Replication protein A (RPA) is a heterotrimeric
(70, 32 and 14kDa subunits), single-stranded DNA-
binding protein required for cellular DNA metabo-
lism. All subunits of RPA are essential for life, but
the specific functions of the 32 and 14kDa subunits
remains unknown. The 32kDa subunit (RPA2) has
multiple domains, but only the central DNA-binding
domain (called DBD D) is essential for life in
Saccharomyces cerevisiae. To define the essential
function(s) of RPA2 in S. cerevisiae, a series of
site-directed mutant forms of DBD D were gener-
ated. These mutant constructs were then character-
ized in vitro and in vivo. The mutations had minimal
effects on the overall structure and activity of the
RPA complex. However, several mutants were
shown to disrupt crosslinking of RPA2 to DNA and
to dramatically lower the DNA-binding affinity of a
RPA2-containing subcomplex. When introduced
into S. cerevisiae, all DBD D mutants were viable
and supported normal growth rates and DNA repli-
cation. These findings indicate that RPA2–DNA
interactions are not essential for viability and
growth in S. cerevisiae. We conclude that DNA-
binding activity of RPA2 is dispensable in yeast
and that the essential function of DBD D is intra-
and/or inter-protein interactions.
INTRODUCTION
Replication protein A (RPA) is a eukaryotic, single-
stranded DNA (ssDNA)-binding protein; RPA binds
ssDNA with high aﬃnity and low speciﬁcity (1–3). RPA
is highly conserved throughout evolution and has been
found in all eukaryotes examined (1,4). RPA’s two
major functions are to bind ssDNA and to interact with
proteins. These interactions are essential for cellular DNA
replication, repair and recombination. RPA has also been
implicated in the regulation of transcription and in the
coordination of DNA metabolism with other cellular pro-
cesses (1–3).
RPA is a heterotrimer composed of three structurally
related subunits of 70, 32 and 14kDa (RPA1, RPA2 and
RPA3, respectively). All three subunits are essential for
formation of a stable, functional RPA complex, and all
three genes have been shown to be essential in yeast (the
gene for RPA1 is referred to as RFA1, RPA2 is RFA2 and
RPA3 is RFA3 in yeast) (5). The 70kDa subunit is com-
posed of four OB fold domains required for both DNA
and protein interactions (6). The 32kDa subunit contains
three domains: an N-terminal ﬂexible domain (7,8), a cen-
tral, essential, OB-fold domain designated DNA-binding
domain (DBD) D and a C-terminal protein-interaction
domain. The 14kDa subunit contains only one domain;
this OB-fold domain (DBD E) appears to be primarily
a structural component of the RPA complex (9) though
contacts between it and ssDNA have recently been
detected (10–12).
All of the OB folds in RPA can interact with ssDNA.
Structural and crosslinking analyses suggest that the
domains bind with a 50 ! 30 polarity (13–15). Of the
four domains in RPA1 (F, A, B and C), DBD A and B
form a high-aﬃnity DNA-binding core (16,17), while
DBD F and C both bind with weaker aﬃnity (3,18).
DBD D in RPA2 has been shown to interact with DNA
in the context of the heterotrimer (19–22), but can also
weakly bind DNA as a subcomplex with RPA3 (23,24).
DBD E in RPA3 has recently been shown to bind to
telomere sequences and to contact ssDNA when the
RPA complex binds to ssDNA (10,11).
The exact mechanism by which RPA modulates its
interactions with various DNA substrates is unknown.
RPA undergoes multiple conformational changes in the
presence of ssDNA (25), which is in part dependent on
the length of the DNA substrate (26). Analysis of RPA
mutations in the conserved aromatic residues in each
DBD imply that the diﬀerent DBDs are involved in inter-
actions with diﬀerent lengths of ssDNA (19). This is sup-
ported by cross-linking studies, where RPA1 associates
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tails, but RPA2 is primarily crosslinked to DNA duplexes
containing long (30nt) ssDNA tails (21,27,28). This may
be functionally important, as RPA2 has been shown to
initially cross-link to the growing DNA chain during
DNA replication in isolated nuclei (29,30).
The data discussed earlier have lead to several models of
DNA binding by RPA and implicated RPA2–DNA inter-
actions in regulation of RPA function. It has been sug-
gested that DBDs A and then B, the high-aﬃnity core,
ﬁrst bind to a small region of DNA. This is followed by
binding of DBDs C and D to form a stable, 30-nt binding
mode (3). There is also evidence for a tighter packing of
RPA on ssDNA at high RPA to DNA ratios
(19,21,27,28). In this 10-nt binding mode, it is thought
that DBDs A and B are primarily interacting with the
DNA. It has also been suggested that the interactions of
DBD C and D with DNA are modulated by interactions
with other proteins and that this regulates RPA function
and promotes the departure of RPA from ssDNA (3,30).
This model, called the handoﬀ model, predicts that
RPA2–DNA interactions are important for the cellular
function of RPA.
There is little direct evidence on the role of RPA2–DNA
interactions in vivo. There have been two previous studies
analyzing the function of RPA2 mutants (rfa2)i n
Saccharomyces cerevisiae (31,32). Mutations in RFA2
have signiﬁcant phenotypes including reduced growth,
temperature sensitivity, DNA damage sensitivity and
increased rates of spontaneous mutation. The most
severe phenotypes have been observed with mutations in
DBD D and DBD D domain is the only region RPA2
shown to be essential for viability in yeast (33).
However, several of the rfa2 mutants with strong pheno-
types also caused decreased protein stability and/or com-
plex formation. Therefore, it is unresolved whether the
phenotypes resulted from altered DBD D function or
decreased structural stability. It is currently not known
what activities of RPA2 are essential for RPA function
in the cell.
The goal of these studies was to determine the role of
DBD D of RPA2. Current studies have suggested three
possible, but not mutually exclusive, functions for this
domain: DNA-binding, regulation (protein interactions)
and structural (complex formation). Using existing struc-
tures for RPA domains and the sequence homology
between RPA domains, we have generated a series of
mutant forms of yeast RPA2 with changes in predicted
DNA-binding site of DBD D. These mutants were then
analyzed for biochemical function and their ability to
function in the cell. All mutant forms were able to form
complexes with the other subunits of RPA in vitro and
were viable in vivo. Several of the mutants had altered
conformations based on cross-linking analysis and were
sensitive to DNA damaging agents. However, these phe-
notypes did not correlate with reduced RPA2–DNA inter-
actions. These studies demonstrate that RPA2–DNA
interactions are not an essential function of this subunit.
This analysis suggests that RPA2 is necessary for struc-
tural integrity and may also be needed for intra- and/or
inter-protein interactions.
MATERIALS AND METHODS
Materials
Oligonucleotides were synthesized by either Sigma
(St Louis, MO) or Integrated DNA Technologies
(Coralville, IA). Hydroxyurea (HU) was purchased from
Sigma-Aldrich (St Louis, MO). The parent vector YCp52
was a gift from Bob Deschenes (Medical College
of Wisconsin). S4-dUTP (4-thio-20-deoxyuridine-
50-triphosphate) was kind gift of V. Bogachev (Institute
of Chemical Biology and Fundamental Medicine,
Russia). DNA polymerase b isolated according to (34)
was a kind gift of Dr S Khodyreva (Institute of
Chemical Biology and Fundamental Medicine, Russia).
The HI buﬀers used for protein puriﬁcation and ﬂuo-
rescence polarization (FP) contained 30mM HEPES
(diluted from a 1M stock, pH 7.8), 5mM MgCl2, 0.5%
(w/v) inositol, 1mM dithiothreitol and indicated concen-
tration of KCl (e.g. HI-100 contains 100mM KCl).
Nomenclature
This manuscript will refer to the mutant forms of yeast
RPA2 according to the abbreviations listed in Table 1.
Mutant RPA subunits will be referred to as RPA2 (muta-
tion), the trimeric RPA complex containing this mutation
will be listed as RPA 2(mutation), the dimeric subcom-
plex containing this mutation will be RPA2(mutation)/
3 and the gene will be referred to as rfa2-mutation. For
example, the forms of the K135A, F137A mutation (sub-
unit, complexes and yeast gene) will be referred to as
RPA2(KF), RPA 2(KF), RPA2(KF)/3 and rfa2-KF,
respectively.
Construction of mutationsin RPA2
Site-directed mutagenesis was carried out using the
QuikChange Site-Directed Mutagenesis kit or the
QuikChange Multi Site-Directed Mutagenesis kit
(Stratagene, La Jolla, CA). Primers contained changes
that would either result in the conversion of polar/
charged/aromatic residues to alanine residues or result in
silent or conserved mutations that generated/eliminated
restriction sites (Table 1). All constructs were sequenced
at the DNA Core Facility (University of Iowa).
All RPA2 mutants in trimeric RPA, with the exception
of RPA 32(W101A, F143A), were generated by site-
directed mutagenesis of the plasmids p11d-tscRPA (23),
pET28a-RFA2,RFA3 (35) or prs315-RFA2 (35). To gen-
erate constructs containing all three RPA genes, RFA1
was cloned into pET28a-RFA2,RFA3 containing the
desired mutation or by site-directed mutagenesis of plld-
scRPA (35). Mutant RPA 2(W101A, F143A) was
expressed from the plasmid pSAS203, a gift from Steve
Brill (Rutgers University, NJ). RPA2/3 dimers were
expressed from the vector pET28a-RFA2/RFA3 (35).
Mutants were made by direct mutagenesis of pET28a-
RFA2/RFA3 using the QuikChange II Site-Directed
Mutagenesis kit (Stratagene, La Jolla, CA) with the
respective primers (Table 1) or by mutagenesis in addi-
tional vectors followed by subcloning into pET28a-
RFA2,RFA3.
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mutants were made by using the QuikChange Site-
Directed Mutagenesis Kit (Stratagene, La Jolla, CA)
with the respective primers (Table 1) directly in
prs315-RFA2 or in were subcloned into prs315-
RFA2 (35).
Expression andprotein purification of RPAcomplexes
Heterotrimeric RPA complexes were expressed and
puriﬁed as described previously (36).
RPA dimeric subcomplexes were expressed using
pET28a constructs that contained wild-type RFA3 and
wild-type or mutant RFA2 containing a His-tag on the
N-terminus. Each expression plasmid was transformed
into BL21(DE3) cells, grown, induced and lysed as
described for trimeric RPA (36). After cell lysis, the solu-
ble fraction (60ml at 30mg/ml) was loaded onto 60ml of
Nickel resin (Qiagen, Valencia, CA) that had been washed
in HI-100mM KCl. The column was washed in HI-
100mM KCl buﬀer with a gradient of 0–10mM imidazole
for three column volumes. It was then washed in HI-
100mM KCl buﬀer with a gradient of 10–300mM imida-
zole for 10 column volumes followed by two column
volumes of HI-100mM KCl, 500mM imidazole. RPA2/
3 eluted at a concentration of  135mM imidazole,
100mM KCl. RPA-containing fractions were loaded
onto a Mono-Q column equilibrated with HI-50mM
KCl. The column was washed sequentially with four
column volumes of HI-50mM KCl and HI-100mM KCl
prior to elution with 10 column volumes of linear salt
gradient in HI-buﬀer containing 200–400mM KCl. RPA
2/3 eluted as a single peak at  200mM KCl. RPA2/3 was
then concentrated to 25–30mg/ml in HI-100 buﬀer using
Centricon tubes with a 3000 molecular weight cut oﬀ. All
protein concentrations were determined by a Bradford
assay using BSA as a standard (37).
Fluorescence polarization (FP)assays
DNA-binding assays were carried out as described pre-
viously (36). Eighty-microliter reactions containing HI
buﬀer with the indicated salt, RPA and ﬂuorescein-
conjugated ssDNA were assembled at room temperature
in the wells of black 96-well FluoroNunc plates (Nalge
Nunc International, Rochester, NY). Trimeric RPA com-
plexes were assayed over a concentration range of
0–1000nM. The high salt concentrations were required
to obtain equilibrium-binding conditions with the RPA
trimer; therefore, RPA trimer-binding assays were carried
out in 1.25M KCl unless otherwise indicated. DNA
(oligo-deoxythymidine 30nt in length with a 50 ﬂuorescein
moiety) was added last to a ﬁnal concentration of 5nM.
Plates were covered with aluminum foil and gently rocked
for 10min to allow sample equilibration. The plates were
then uncovered and assayed for polarization. The excita-
tion wavelength of ﬂuorescein is 480nm with a 30nm
bandwidth, and the emission wavelength is 535nm with
a 40nm bandwidth. Data were collected using a measure-
ment time of 0.2s per well. Anisotropy is deﬁned as r
or R=(Ivv   Ivh)/(Ivv+2GIvh), where Ivv is the vertically
excited and vertically emitted light and Ivh is the vertically
excited and horizontally emitted light. G is an instrumen-
tal correction factor. Polarization is deﬁned as P=3r/
2+r. Data were analyzed by ﬁtting to the Langmuir-
binding equation as described by Kim et al. (38). All bind-
ing experiments were performed three to six times.
Experiments with RPA dimers were performed as
described earlier with the following modiﬁcations.
Dimeric RPA was titrated from 0 to 100mM. Viscosity
was also controlled in these experiments by adding BSA
so that the BSA and RPA together equaled a total pro-
tein content of 3.65mg. The ﬁnal salt concentration was
100mM NaCl, 21mM KCl and 5mM MgCl2. Plates were
covered with aluminum foil and gently rocked for 60min
to allow sample mixing and protein binding.
Yeaststrains
TWY177 (mec1-1; MAT a, leu2, ura3, his3, trp1) was a gift
from Ted Weinert (University of Arizona). WY2 (MAT a,
leu2, ura3, ade2, ade8, his3, met4) was a gift from Bob
Deschenes (Medical College of Wisconsin). AMSY-1
(MAT a, leu2, ura3, ade2, ade8, his3, met4, rfa2:Km
r)
was derived from WY2 and has a chromosomal knockout
of the RPA2 gene (35). The rad52-1 (MAT a, ade2, lys2,
tyr1, ura3, cyn2, his7) construct was a gift from Bob
Malone [University of Iowa (39)].
Yeastmethods
The plasmid YCp52-RFA2, containing a wild-type copy
of the RFA2, ADE8 and URA3 genes, was transformed
into AMSY-1. The RPA2 mutant genes used for in vitro
assays were cloned into the yeast vector prs-315 that
contained a LEU2 biosynthesis gene and were then trans-
formed into the yeast strain AMSY1 by using the Frozen-
EZ Yeast Transformation II kit (Zymo Research, Orange,
CA). The plasmid YCp52-RFA2 that contained the wild-
type copy of RFA2 was then exchanged for the pRS315
plasmid that contained the mutant form of RFA2 by
growing the cells in leucine-deﬁcient media. When plated
on YEPD, cells that had lost the YCp52-RFA2 plasmid
were white and cells that retained the plasmid were red.
White cells were selected and streaked on sc-Ura/glc and a
master plate of sc-Leu/glc. Cells that had lost the wild-
type RFA2 plasmid could not grow on sc-Ura/glc but
could grow on the master plate of sc-Leu/glc and were
used for further analysis.
Plasmid stability was determined based on the rate of
loss of a non-essential plasmid (31). AMSY-1 cells con-
taining the various prs315-mutant rfa2 plasmids were
transformed with YCp50. Cultures were then grown to
log phase in sc-Ura media, transferred to the rich, non-
selective YEPD media and grown overnight. Cells were
then plated on YEPD and –Ura media. Plasmid loss
rates were calculated by comparing the number of colonies
on –Ura plates to the number of colonies on YEPD plates.
Plasmid loss rate is compared to the loss rate of strain
containing wild-type RFA2.
Sensitivity to DNA damagingagents
AMSY1cells were grown to log phase and then serial dilu-
tions (10mlo f1 0
3,1 0
4,1 0
5 and 10
6cells/ml) were plated on
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determined using YEPD plates containing 0.1M HU. UV
sensitivity was determined by exposing plates to UV doses
of 0–200J/M
2 and incubating in the dark to prevent repair
by photolyase. After growth, plates were assessed for the
number of remaining viable colony-forming units. All
mutants were examined in two or more independent
experiments.
Synthesis of photoreactive DNA structures
Photoreactive DNA structures were made by using the
activity of DNA polymerase b to add a photoreactive
4-thio-dUMP residue to the 30-end of a primer in a
primer-template (27). Ten microliters of reaction mixtures
containing 50mM Tris–HCl pH 7.5, 50mM NaCl, 5mM
MgCl2,2 0 mM DNA-duplex, 5.6mM DNA polymerase
b and 1mM 4-thio-dUTP (4-thio-20-deoxyuridine-
50-triphosphate) were incubated for 20min at 378Ct o
allow elongation of the primers. Subsequently, the mix-
tures were incubated at 708C for 5min, cooled slowly
and centrifuged to remove precipitated DNA polymerase
b. To check the resulting annealing eﬃciency, aliquots
1mM of the sample volume were brought to a ﬁnal con-
centration of 5% Ficoll-400 and 0.05% bromophenol blue
and electrophoresed on a 12% polyacrylamide gel con-
taining 89mM Tris–HCl pH 8.8, 89mM boric acid and
2mM EDTA at 100V/cm. Radioactive bands were visua-
lized by autoradiography.
Photochemical crosslinking
Reaction mixtures (10ml) contained 50mM Tris–HCl pH
7.5, 50mM NaCl, 5mM MgCl2, 2.5 mg BSA, 0.01%
Tween, 0.1mM5 0-[
32P]-labeled photoreactive DNA and
the indicated amounts of RPA or one of its mutant
forms (from 0.3 10
 7 to 2.5 10
 7M). The reaction
mixtures were preincubated in micro-Eppendorf tubes
for 10min at 378C and UV-irradiated on ice through the
open top. The probes were irradiated for 45min. A Lomo
VIO-1 UV-crosslinker (St Petersburg, Russia) equipped
with lamps producing UV-light of 334–365nm was used
as light source. Reactions were stopped by adding
Laemmli loading buﬀer and heating for 5min at 958C.
The photochemically crosslinked protein–DNA samples
were separated by 12.5% SDS–PAGE. Gels were dried
and subjected to autoradiography using a ‘Molecular
imager FX Pro+’ (BioRad) screen.
RESULTS
Sequencealignments and identification ofputative
DNA-interacting residues in RPA2
The structure of yeast RPA2 has not been determined and
there are no structures of any RPA2 subunit interacting
with ssDNA. Overall, the amino acid sequences of human
and yeast RPA are 44% similar with the DBDs having the
highest level of conservation (1,5). Therefore, sequence
homology was used to identify the putative DNA-binding
interface of yeast RPA2. The crystal structure of the high-
aﬃnity DNA-binding core (DBD A and DBD B) of
human RPA1 bound to DNA has been determined (13).
The structure of DBD A from the yeast 70kDa subunit is
similar to the homologous domain of human RPA and the
residues that interact with DNA are similar (40). Mutation
of individual polar residues that interact with DNA
dramatically and additively decreased RPA’s aﬃnity for
ssDNA (16,41). By analogy, we hypothesized that the
DNA-interaction site of RPA2 would contain a combina-
tion of polar and aromatic residues that interact directly
with DNA. Furthermore, we predicted that mutation of
these residues would disrupt binding of RPA2 to DNA.
The amino acid sequences of human RPA1 core DBDs
(DBD A and DBD B) were aligned with the DBD D
sequences from yeast and human RPA2 (Figure 1A).
The residues known to interact with DNA in RPA1 are
in red (Figure 1A) and polar or aromatic residues in sim-
ilar positions in RPA2 in blue (Figure 1A). All the identi-
ﬁed residues were highly conserved between the six
sequenced Saccharomyces genomes and showed partial
conservations between more distantly related fungal spe-
cies (data not shown). These residues were targeted as
putative DNA-binding residues in our mutagenesis and
each was mutated to alanines to disrupt the putative
DNA-binding site of RPA2. Eight mutant genes were gen-
erated with each containing two to three of the putative
DNA-interacting residues mutated to alanine (Table 1).
In addition, two combination mutants, termed multi-
mutants, were generated that contained seven (D80A,
T82A, E97A, R99A, K100A, K146A, K147A) and six
alanine (D80A, T82A, E103A, D104A, D158A, E162A)
substitutions, these will be referred to as RPA2(MM1)
and RPA2(MM2), respectively (Table 1).
Each of these residues was also mapped onto the struc-
ture of human RPA2 (Figure 1B). The structure of human
RPA2 has a very shallow putative DNA-binding cleft rel-
ative to the OB-folds in the DNA-binding core of RPA1
(24,42) (see upper right model in Figure 1B). Nevertheless,
most of the putative DNA-binding residues identiﬁed by
homology with RPA1 were modeled to be in or near the
putative binding cleft of the human RPA2 structure. Two
mutants, RPA2(SN) and RPA2(DE), were predicted to be
near to intersubunit interface of RPA2 (Figure 1B) (43).
However, because the structure of yeast RPA2 is not
known and the role of individual regions of RPA2
poorly understood, these mutants were also analyzed to
determine their eﬀect on RPA2 DNA-binding and cellular
function. Taken together, this set of mutations represents
a directed alanine-scan of the DBD of RPA2.
Biochemical characterization ofRPA2 mutants
Each of the mutant forms of RPA2 was expressed with the
two other RPA subunits in E. coli and the resulting RPA
complexes were puriﬁed (Supplementary Figure 1). All
the mutant forms puriﬁed as heterotrimeric complexes
with yields similar to that of wild-type RPA. This shows
that all of the mutants were stable and interacted with
the other two RPA subunits to from heterotrimeric
complexes.
The DNA binding of the mutant RPA complexes was
analyzed by gel mobility shift (GMSA) and FP assays.
2316 Nucleic Acids Research, 2009, Vol. 37,No. 7Figure 1. RPA DBD D mutants. (A) Sequence alignment of protein sequence of human DBD A (residues 181–289), B (residues 302–442) and D
(residues 45–171) and yeast DBD D (residues 40–174). The amino acid sequences aligned by Clustal W. Residues from human RPA known from the
crystal structure of DBD A and B to interact with DNA are shown in red. Mutations made in S. cerevisiae DBD D are indicated in blue. Mutated
residues that are conserved between humans and yeast RPA2 are starred. Dashes indicate a gap in the alignment. (B) Models of DBD mutant forms.
The crystal structure of human DBD D was used to model equivalent primary residues (aligned by Clustal W) that had been mutated in yeast DBD
D using RasMol. In all the models, the DNA-binding cleft is on the top and the intersubunit interface (which includes the horizontal alpha helix) is
on the bottom. To help the reader orient the models, the upper right model has the putative position of DNA indicated by a black dot and the
intersubunit interface labeled. The mutated yeast residue side chains were modeled onto the homologous residue in the human DBD D structure and
shown in color (stick form). All residues were mutated to alanine. Mutants shown: RPA2(SN), homologous human residues D151,N153; RPA2(KF),
human residues K127,A129; RPA2(DT), human residues K85,P87; RPA2(ERK), human residues D103,R105,Q106; RPA2(KK), human residues
K138,K139; RPA2(DE), human residues E150,E159; RPA2(ED), human residues D109,T110; RPA2(WF), human residues W107,F135;
RPA2(MM1) is composed of DT, ERK and KK, human residues K85,P87,D103,R105,Q106,K138,K139; RPA2(MM2) is not shown.
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oligonucleotides between 20 and 40nt. The association
constants determined for each of the heterotrimeric
mutant complexes were not statistically diﬀerent from
that of wild-type RPA (data not shown). To try to
deﬁne any subtle diﬀerences in DNA-binding activity,
a subset of the mutants was also analyzed by ﬂuorescence
polarization (FP). FP is a direct technique that measures
the anisotropy of a ﬂuorescently labeled DNA probe when
it is titrated with protein. An advantage of FP is that it can
be used to directly determine apparent binding constants
under a variety of solution conditions. Thus, it was pos-
sible to directly determine the binding constant under
equilibrium conditions. RPA 2(ERK), RPA 2(DT),
RPA 2(MM1) and RPA 2(MM2) had binding constants
equivalent to wild-type RPA (Figure 2). In contrast,
RPA 2(WF) had slightly reduced binding to dT30 (Ka
of RPA=1.6 10
8 and Ka RPA 2(WF) = 3.85 10
7;
P=0.018). RPA 2(MM1) and RPA 2(MM2) had wild-
type binding in all assays examined. Each of the multi-
mutants contained three sets of mutations (Table 1).
These results strongly indicate that none of the mutations
contained in the two multi-mutants (DT, ERK, KK, DE
and ED) had a signiﬁcant eﬀect on binding either individ-
ually or in combination. We conclude that none of the
mutant forms of RPA2 except for RPA 2(WF) eﬀect
binding of the RPA complex to ssDNA but that the
RPA complex containing RPA 2(WF) has only a slightly
reduced aﬃnity for DNA. These data conﬁrm previous
work that showed that mutations in DBD D have
only subtle eﬀects on overall binding to DNA but that
the aromatic mutant (W101A,F143F) reduced the aﬃnity
of DBD D (19).
Viability, growth and plasmid stability of rfa2mutants
We next analyzed their properties in yeast cells. Each
mutant form of RPA2 was placed under the control of
the endogenous RFA2 promoter on a low copy yeast
Table 1. Nomenclature of mutants
Mutations in yeast RPA2 Abbreviation Primers Restriction site
S159A,N161A SN AAG CCC ATA GAT GCA TTC GCA GAA GTG TTG ACG CAT CAC NsiI
GTG ATG CGT CAA CAC TTC TGC GAA TGC ATC TAT GGG CTT
V134V,K135A,F137A KF GAA ATT GGC GGT TAC GTC GCA GTT GCA GGT GCT TTG AAA GAG [SnaB1]
CTC TTT CAA AGC ACC TGC AAC TGC GAC GTA ACC GCC AAT TTC
T79T,D80A,T82A DT GGT GTG GTG AGA AAC ATT ACT GCG CAT GCT GCA AAT ATT FspI
AAT ATT TGC AGC ATG CGC AGT AAT GTT TCT CAC CAC ACC
L96I,E97A,R99A,K100A ERK GA ACT GGT CAA TTG GCA GTG AGA AAA TGG AGC GAA GAT G MfeI
CAT CTT CGC TCC ATT TTC TCA CTG CCA ATT GAC CAG TTC
GA ACT GGT CAA TTA GCA GTG GCA GCA TGG AGC GAA GAT G [MfeI]
CAT CTT CGC TCC ATG CTG CCA CTG CTA ATT GAC CAG TTC
G145G,K146A,K147A KK GCT TTG AAA GAG TTT GGT GGC GCC GCA AAT ATA CAG KasI
CTG TAT ATT TGC GGC GCC ACC AAA CTC TTT CAA AGC
D158A,E162A,V163V DE AAG CCC ATA GCT TCA TTC AAT GCAG T T TTG ACG CAT [HincII]
GAT GCG TCA AAA CTG CAT TGA ATG AAG CTA TGG GCT T
E103A,D104A ED GA AAA TGG AGC GCG GCC GCA AAT GAC TTG GC EagI
GCC AAG TCA TTT GCG GCC GCG CTC CAT TTT C
W101A,F143A,G144G WF GAA GTG AGA AAA GCT AGC GAA GAT GCA NheI
TGC ATC TTC GCT AGC TTT TCT CAC TTC
GGT GCT TTG AAA GAG GCC GGC GGT AAG AAA AAT A NgoMIV
TAT TTT TCT TAC CGC CGG CCT CTT TCA AAG CAC C
T79T,D80A,T82A,
L96I,E97A,R99A,K100A,
G145G,K146A, K147A
MM1 same as for DT, ERK, KK FspI, MfeI, KasI
T79T,D80A,T82A,D158A,
E162A,V163V, E103A,
D104A
MM2 same as for DT, DE, ED FspI, EagI, NheI
Desired mutations shown in bold, conservative mutations used to aid cloning shown in plain text. Nucleotide changes in primers indicated in bold.
Restriction site created or [eliminated] indicated in ﬁnal column.
Figure 2. Aﬃnity of yeast heterotrimeric RPA complexes containing
mutations in RPA2 for dT30. Binding constants of wild-type or
mutant forms of RPA were determined by FP assays at 1.25M KCl.
The average association constant (Ka) for each mutant is presented.
The experiments were performed at least three times with the standard
deviation shown.
 The only mutant that had an association constant
that was statistically diﬀerent than wild-type (using a one-way ANOVA
with a Tukey post hoc analysis) was RPA 2(WF).
2318 Nucleic Acids Research, 2009, Vol. 37,No. 7plasmid. These genes are each designated rfa2-‘mutation’
using standard yeast terminology. Each was then analyzed
in a RPA2 knockout strain, AMSY1 (generated by dis-
rupting the RFA2 genomic locus with a kanamycin resis-
tance gene).
All of the DNA-binding domain mutants were capable
of supporting life; all were able to support growth when
they were the only form of rfa2 in the cell (Table 2).
Growth was also observed at 378Co r2 5 8C (Table 2).
All the mutants had wild-type growth rates at 308C
(Table 2). We conclude that all of these mutants were
able to support chromosomal DNA replication and
other essential cellular processes.
rfa2mutant responses to ultraviolet irradiation
Previously, RPA2 mutations have been shown to cause
defects in DNA repair after exposure to UV light
(31,32). Cells containing the mutant forms of rfa2 were
exposed to diﬀerent levels of UV radiation and the
number of viable cells determined. Two strains were
used as controls: a deletion of the C-terminal winged-
helix domain of RPA2 [rfa2-Dwh; (31)] and rad52-1. The
RAD52 epistasis group is involved in homologous recom-
bination, and it is not the major pathway by which cells
repair UV-induced lesions. Thus, mutants with defects in
the RAD52 epistasis group are only partially sensitive to
UV; they show sensitivity only at high doses of radiation
as observed in the experiment shown in Figure 3. Cells
containing rfa2-wh are temperature sensitive and sensi-
tive to methyl methane sulfonate but are not sensitive
to UV damage at 258C (31). Only three of the new
rfa2 mutant strains were found to have minimal UV-
sensitivity: rfa2-WF, rfa2-ERK and rfa2-MM1, which
contains rfa-ERK (Figure 3). Strain rfa2-ERK and
rfa2-MM1 had an intermediate UV phenotype, with sen-
sitivity between wild-type RFA2 and the rad52-1 control
(Figure 3). A similar phenotype was observed in a second
RFA2 knockout strain, AWY1 (data not shown). Mutant
strain rfa2-WF also had a weak but reproducible decrease
in colony number indicated a slight UV sensitivity in both
AMSY1 and AWY1 strains (Figure 3 and data not
shown). All other DBD-D mutants showed no increase
in UV sensitivity (Figure 3).
One explanation for the UV sensitive phenotype could
be that these mutations aﬀect protein stability. Indeed,
characterization of most published rfa2 mutants suggests
that the lethal phenotypes at 378C were due to disrupted
complex formation or decreased RPA2 stability (31,32).
To rule out altered protein levels as the cause of the
observed phenotypes of the mutants, western analysis
was performed with yeast extracts from cells containing
rfa2-WF, rfa2-ERK and rfa2-MM1. Other strains wild-
type RFA2, rfa2-DT and rfa2-MM2 were included as con-
trols. The membranes were incubated with antibodies
against actin and RPA2 (Supplementary Figure 2).
Quantiﬁcation of the bands observed followed by statisti-
cal analysis indicated that all mutants had wild-type pro-
tein levels. This suggests that the modest phenotypes
present in these mutants were not caused by either under-
expression or overexpression of the mutated proteins.
Since the most sensitive DBD D mutants were less sen-
sitive to UV than rad52-1, a protein not directly involved
in UV damage recovery, we conclude that DBD D only
makes a minor contribution to UV damage recovery.
This modest phenotype appears to be caused by a
change in protein activity with these mutants.
rfa2mutanteffects on DNA replication
HU is a potent inhibitor of ribonucleotide reductase,
which inhibits DNA replication and causes replication
fork stalling by reducing the deoxynucleotide pools in
the cell. We examined the sensitivity of rfa2 strains to
Table 2. Summary of mutant phenotypes
Yeast mutant Growth Doubling time
308C (min)
Growth
HU
Growth
UV
Plasmid
loss (%)
Dimer binding
Ka (M
 1)
258 308 368
RFA2 ++ +1 7 1  14 + + 31 3 1.5 10
4
rfa2-SN + + + 148 + +
rfa2-KF + + + 160 11 + +  0.1 10
4
rfa2-DT + + + 163 15 + + 36 5
rfa2-ERK + + + 168 22 +/– +/– 40 5
rfa2-KK + + + 166 5+ +
rfa2-DE + + + 167 9+ +
rfa2-ED + + + 162 12 + +
rfa2-WF + + + 165 10 +/– +/– 32 3  0.15 10
4
rfa2-MM1 + + + 181 23 +/– +/– 44 9  0.6 10
4
rfa2-MM2 + + + 179 20 + +
sec 23 +– –
rfa2- wh + +/– – +/–
mec1-1 –
rad52-1 –
Phenotypes of RPA mutants indicated. Growth of AMSY1 cells containing the indicated rfa2 gene on a plasmid is indicated at diﬀerent temperatures
or with the indicated DNA damaging agent (+ growth, +/– reduced or slow growth, – no growth). Data for selected control strains is also shown:
sec23 is temperature sensitive, mec1-1 is HU sensitive and rad52-1 is weakly UV sensitive; rfa2-Dwh [deletion of the C-terminal winged-helix domain
of RPA2; (31)] has been shown to have a weak UV sensitive phenotype. The ability of selected strains to support the replication of a non-selected
plasmid (plasmid loss) is also shown. Estimated DNA binding constants for selected RPA2/3 complexes is also shown. Blank—not determined.
Nucleic Acids Research,2009, Vol.37, No. 7 2319HU treatment, as compared to a Mec1 kinase mutant
mec1-1. Mec1 is the yeast homologue of the damage
response kinase ATR and is the primary sensor for col-
lapsed replication forks.
Of the 10 mutant rfa2 genes examined in AMSY1, only
mutant strains rfa2-WF, rfa2-ERK and its derivative rfa2-
MM1 had modest slow-growth phenotypes when grown
on plates containing 0.1M HU (Figure 4). Similar num-
bers of colonies were observed with these mutant strains
but in all cases the colonies observed were much smaller
that wild-type or other rfa2 mutant strains. This pheno-
type was modest compared with the mec1-1 strain, which
was inviable at this concentration of HU (Figure 4). A
subset of the mutants was examined in a diﬀerent strain,
AWY1. They were less sensitive to HU in this back-
ground, with only the mutant strain rfa2-(ERK) having
detectable HU sensitivity (data not shown). These ﬁndings
suggest that the sites mutated in DBD-D are not essential
but may play a modest role in the cellular response to
collapsed DNA replication forks in yeast.
All yeast chromosomes have multiple origins of replica-
tion and contain essential genes: therefore, it is diﬃcult to
detect partial defects in DNA replication by chromosome
loss or viability assays. To examine DNA replication of a
non-essential episome, we determined plasmid loss rates
for selected mutant strains including wild-type, rfa2-DT,
rfa2-WF, rfa2-ERK and its derivative rfa2-MM1. In these
experiments, cells were grown with a plasmid under non-
selecting conditions and the rate at which the plasmid was
lost determined. Elevated plasmid loss rates indicate
reduced eﬃciency of DNA replication. All the strains
lost the non-selected plasmid at rates comparable to that
of a strain containing wild-type RPA2 (data not shown,
summarized in Table 2). These ﬁndings indicate that none
of the mutations have an eﬀect on plasmid DNA replica-
tion under these growth conditions.
Cumulatively, these analyses (summarized in Table 2)
suggest that the mutations made in the putative DNA-
binding site of DBD D have no eﬀect on growth and
DNA replication, but in some cases, show minor defects
in DNA damage response. We conclude that these muta-
tions have minimal eﬀects on RPA function in the cell.
Effects ofmutations on theintrinsic affinityof RPA2
The ﬁndings that these mutations have minimal eﬀects
on the biochemical activity of the RPA complex and
no or modest phenotypes in vivo raise the question of
to what extent the mutations have directly aﬀected the
Figure 3. Sensitivity of rfa2 mutant strains to UV. AMSY1 cells containing the indicated rfa2 gene on a plasmid were grown at 308C to log phase
(OD600  0.5) and the indicated number plated on YEPD plates. The plates were irradiated with the respective doses of UV light and incubated in
the dark at 258C for 3 days. Only a subset of the doses is shown. The rad52-1 strain (Bob Malone, University of Iowa) and rfa2-Dwh [deletion of the
C-terminal winged-helix domain; (31)] were used as controls.
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low aﬃnity for DNA in comparison with the high aﬃnity
of the RPA complex, making it diﬃcult to determine the
eﬀects of RPA2 mutations on DNA binding of the trimer
complex (23,44). In order to quantitate the DNA-binding
activity of RPA2 directly, it was necessary to analyze
binding of a subcomplex containing only the 32 and
14kDa subunits. Therefore, we expressed and puriﬁed
from E. coli RPA2/3 sub-complexes of two forms that
had no phenotype in vivo [wild type and RPA2(KF)] and
two forms that had a phenotype in vivo [RPA2(MM1) and
RPA2(WF) (Supplementary Figure 1)]. All four of these
subcomplexes forms were expressed at high levels in E. coli
and puriﬁed with similar yields to wild-type RPA2/3 (data
not shown). The aﬃnity of each complex was then ana-
lyzed using FP assays.
Under near-physiological salt conditions (100mM
NaCl, 21mM KCl and 5mM MgCl2), the binding of
heterotrimeric RPA to dT30 was near stoichiometric; it
saturated quickly at  10nM protein and reached a max-
imal polarization value of  400U (Figure 5). Under the
same conditions, a wild-type RPA2/3 subcomplex
required more than four orders of magnitude higher pro-
tein concentrations to bind the same amount of DNA;
binding reached near saturation at a protein concentration
of 100mM (Figure 5). The physical limitations of the assay
prevented analysis of higher concentrations of protein.
This result indicated that the aﬃnity of RPA2/3 for
DNA is at least four orders of magnitude lower than
that of the trimeric RPA complex.
To conﬁrm this ﬁnding, DNA binding was examined at
other ionic strengths. RPA binding is ionic strength
dependent (45,46). At higher ionic strength, essentially
no binding of the RPA2/3 complex was observed (data
not shown). At low ionic strength (30mM KCl), satura-
tion of binding was obtained at slightly lower protein con-
centrations and the polarization maximum obtained at
saturation was similar to the level of polarization obtained
with wild-type trimeric RPA (data not shown). These stu-
dies demonstrated that similar anisotropy values were
obtained with both trimer and dimer RPA complexes
under stoichiometric-binding conditions. Therefore, we
ﬁt the RPA2/3 subcomplex binding data (Figure 5) assum-
ing that polarization would have saturated at the same
maximum polarization observed with the trimeric RPA.
This allowed us to estimate the association constant
of wild-type RPA2/3 for dT30 to be  1.5 10
4M
 1
Figure 4. Growth phenotype of rfa2 strains on HU. AMSY1 cells con-
taining the indicated rfa2 gene on a plasmid were grown at 308C to log
phase (OD600  0.5) and the indicated number plated on YEPD plates
containing 0.1M HU. The plates were incubated at 308C for 3 days.
The mec1-1 strain was used as a control (55).
Figure 5. Aﬃnity of yeast dimeric RPA2/3 complexes containing muta-
tions in RPA2 for dT30 under physiological salt conditions. Increasing
amounts of yeast RPA and yeast dimeric RPA2/3 complexes containing
mutations in RPA2 were incubated with 5nM ﬂuorescein-conjugated
dT30 in 5mM MgCl2, 21mM KCl and 100mM NaCl buﬀer and ﬂu-
orescence polarization determined. The raw data from wild-type, tri-
meric RPA (triangles); RPA2/3 (circles); RPA2(WF)/3 (squares);
RPA2(KF)/3 (inverted triangles), and RPA2(MM1)/3 (diamonds) are
shown. Data were ﬁt to a langmuir binding isotherm (curves shown).
Insert. The association constant for wild-type RPA2/3 (2/3) and upper
limit estimated association constants for RPA2(KF)/3 (KF),
RPA2(WF)/3 (WF) and RPA2(MM1)/3 (MM1) are shown.
Reproducibility of the assay is indicated by error bars.
 The upper
limit estimates of all three mutants were statistically diﬀerent than
wild-type (using a one-way ANOVA with a Tukey post hoc analysis).
Nucleic Acids Research,2009, Vol.37, No. 7 2321(Figure 5). This association constant is ﬁve orders of
magnitude lower than that of the trimeric yeast RPA
complex (23).
All three mutant subcomplexes appeared to bind to
DNA with a lower aﬃnity than the wild-type subcomplex.
Addition of up to 100mM of RPA2(KF)/3, RPA2(WF)/3
or RPA2(MM1)/3 resulted in polarization signals either at
or slightly above background (Figure 5). It was not pos-
sible to determine the absolute binding aﬃnity for these
mutant complexes. However, assuming (1) that the small
changes in polarization signal observed with the mutants
were caused by binding and (2) that the isotherms would
have saturated if suﬃcient protein was added, we esti-
mated the maximum binding constants for each of the
mutant subcomplexes (curves shown for mutant forms in
Figure 5). This analysis provided estimates of the upper
limit for the binding constants of these mutant forms: 10,
10 and 40% that of wild-type dimer for RPA2(KF)/3,
RPA2(WF)/3 and RPA2(MM1)/3, respectively (Table 2;
Figure 5, insert). These diﬀerences are statistically signif-
icant from wild-type (P<0.001, P<0.001 and P=0.002,
respectively, using a one-way ANOVA followed by a post
hoc Tukey test). We conclude that all three of these
mutants have dramatically lower binding than the wild-
type dimeric complex. These results demonstrate that
these mutations in RPA2 signiﬁcantly decreased RPA2–
DNA interactions.
There was no correlation between in vivo phenotype
observed with these mutants and the DNA-binding aﬃn-
ity of DBD D. Of the three mutant forms examined,
RPA2(MM1) had the strongest phenotype; however, this
mutant also was estimated to have the highest aﬃnity of
the three mutant subcomplexes. RPA2(WF) had a pheno-
type in vivo and eﬀected binding of the trimeric RPA com-
plex (Figure 2) but appeared to have an intrinsic aﬃnity
for DNA that was similar to RPA2(KF), which has
no phenotype in vivo. These data argue that the ssDNA-
binding activity of RPA2 is not essential for RPA function
in the cell.
RPA2interactions withprimer-template junctions
When RPA binds to a partially duplex primed single-
stranded DNA, RPA2 has been shown to crosslink to
the 30 end of a primer strand (21,27,47). This interaction
is believed to reﬂect binding of DBD D with the primer
strand and is dependent on the binding and conformation
of the RPA complex (14,21,27,28). To try to understand
the eﬀects of the RPA2 mutation on the biochemical func-
tion of the RPA complex, we also examined the interac-
tions of the trimeric RPA mutant complexes with primer
template junctions. A single-stranded template strand was
annealed with a 50 radiolabel primer strand that then had
a 4-thio-deoxyuridine incorporated on the 30 terminus
(Figure 6A and B). Using diﬀerent length template strands
allowed us to create primer template junctions with either
a 10 or 30-nt ssDNA tail. The DNA was then incubated
with RPA at diﬀerent protein:DNA ratios, UV irradiated
to activate the photolabel, separated on an SDS–PAGE
gel, and autoradiography was performed to visualize
crosslinked complexes. The extent of RPA2 cross-link is
always compared with crosslinking of RPA1 as an internal
control (Figure 6C).
In previous studies, the amount of crosslinking of RPA2
observed has depended on both the aﬃnity of the complex
and length of the single-stranded region available for
binding (21,27,28). This is thought to reﬂect intrinsic
DNA-binding activity of RPA2 and its position in the
RPA–DNA complex. When crosslinking of the mutant
complexes were examined with a 10-nt overhang, all
showed reduced crosslinking of RPA2 (Figure 6D). It
has been observed previously that human wild-type
RPA2 is crosslinked more eﬃciently with a 30-nt overhang
(21,27,28). This increase was observed with all of the
mutants examined (compare ratios in Figures 6C and
6D). In addition, we observed more variation in crosslink-
ing with the 30-nt overhang. RPA 2(DT) crosslinked at
levels near wild-type RPA and the two mutant
RPA 2(WF) and RPA 2(KF) had the lowest levels of
crosslinking to the DNA ( 20% and  40% of wild-
type, respectively; Figure 6E and data not shown). These
data do not distinguish whether these diﬀerences reﬂect a
diﬀerence in the conformation of the RPA–DNA complex
or a change in the interactions of the mutant RPA2 sub-
unit and the DNA (see also ‘Discussion’ section).
RPA 2(WF) had the lowest level of cross-linking of any
of the mutant forms with both DNA substrates. This is
consistent with RPA 2(WF) being the only trimeric com-
plex that had reduced aﬃnity for ssDNA.
Two general conclusions can be drawn from the cross-
linking experiments. First, the reduction in crosslinking
observed with the 10-nt overhang suggests that these
mutants are aﬀecting the DNA-binding activity of DBD
D or are changing the conformation of the RPA–DNA
complex in these RPA complexes. Second, the changes in
crosslinking observed with both substrates do not corre-
late with activity in the cell: RPA 2(WF) had the lowest
level of crosslinking with both substrates and a modest
repair phenotype, RPA 2(KF) had reduced crosslinking
with both DNA substrates but no phenotype, and
RPA 2(ERK) and RPA 2(DT) had higher crosslinking
with the 30-nt overhang but only (ERK) had a phenotype.
This supports the general conclusion that the DNA-
binding activity of RPA2 is not critical for RPA complex
function in the cell.
DISCUSSION
RPA contains six DBDs. All these domains can interact
with DNA (3,11,16–18). Previous studies provide evidence
for multiple interactions between the diﬀerent DBDs of
RPA and DNA. A variety of deletion and mutational
analyses have indicated that DBD A and DBD B are
both necessary and suﬃcient for high-aﬃnity DNA bind-
ing by RPA (16,17). Electron microscopic analysis showed
that human RPA binds as a compact form with short
ssDNA substrates and as an elongated form with long
ssDNA substrates (48). Mutation of aromatic residues in
four DBDs of yeast RPA indicate that DBD A and B are
involved in binding to DNA of all lengths, whereas DBD
C and D seem to contribute modestly to binding to long
2322 Nucleic Acids Research, 2009, Vol. 37,No. 7substrates (19). Two binding modes have been identiﬁed
for yeast RPA; at low salt concentrations, a mode with an
occluded binding site size of 18–21nt was observed while
at high salt concentrations, a larger site size of 26–28nt
was observed (46). Cross-linking analysis has also demon-
strated that multiple domains of RPA are in close prox-
imity to the primer-template junction when RPA binds to
partially duplex-ssDNA (27,28,47). These types of inter-
actions are also observed in situ, where RPA2 is initially
crosslinked to nascent RNA–DNA primers but RPA1
becomes crosslinked as the primers are elongated into
Okazaki fragments (29,30). Together these and other
data have been used to suggest that diﬀerent domains of
RPA bind sequentially to form diﬀerent complexes
depending on the length of the DNA bound (3).
Furthermore, it has been suggested that the positioning
and weak DNA aﬃnity of RPA2 is used to modulate
RPA–DNA binding through interactions with other pro-
teins in a ‘hand-oﬀ’ model of DNA binding (3).
To test these models and to gain a better understanding
of the role of RPA2–DNA binding, we generated and
characterized a series of polar or aromatic residue to
alanine mutations in yeast DBD D with the intent of dis-
rupting RPA2–DNA interactions. These mutations pri-
marily aﬀected residues in the putative DNA-binding
cleft of DBD D but also included some residues predicted
to be in other regions of the domain. These mutants were
then analyzed in vitro and in vivo. None of these mutant
forms aﬀected the formation of the RPA complex in vitro
or the stability of the protein in vivo. All these mutant rfa2
alleles were also viable and supported normal DNA rep-
lication in yeast. Three of the mutant rfa2 strains
(rfa2-ERK, rfa2-MM1 and rfa2-WF) were found to have
modest DNA-repair phenotypes in vivo. All three strains
contained mutations of residues in the putative DNA-
binding cleft and one mutant [RPA2(WF)] caused reduced
binding of the trimeric RPA complex. However, other
mutant forms examined also had mutations in the putative
Figure 6. Photoaﬃnity labeling of yeast trimeric RPA complexes containing mutations in RPA2. (A) Schematic of DNA duplexes used in cross-
linking assays, with radiolabel (asterisk) and photoreactive group (arrow) shown. The upper strand is the primer strand and the bottom strand is the
template. (B) 4-Thio-dUMP photoreactive moiety that is conjugated to the 30 end of the primer. (C) Example of raw data from crosslinking
experiments with wild-type RPA and partial DNA duplexes: left, 10-nt ssDNA tail; right, 30-nt ssDNA tail. For both gels, lane 1: no protein;
lane 2: 1:2 molar ratio of RPA:DNA; lane 3: 1:1 molar ratio; lane 4: 2:1 molar ratio; and lane 5: 2.5:1 molar ratio. (D and E) Quantiﬁcation of a
representative crosslinking experiment. The bars indicate the ratio of intensities of RPA2 to RPA1 crosslinking to DNA duplexes with a 10-nt
overhang (D) or 30-nt (E) overhang at a molar RPA:DNA of 1:1.
Nucleic Acids Research,2009, Vol.37, No. 7 2323DNA-binding cleft (rfa2-DT, rfa2-KK, rfa2-ED and
rfa2-MM2) and had no discernable phenotype in yeast.
Thus, there was no simple correlation between the loca-
tion of the mutations and their eﬀect on cell function.
Direct analysis of DNA-binding activity of the mutated
subunits and crosslinking eﬃciency also did not simply
correlate to the phenotypes of the mutants. For example,
RPA2(KF), which had low ssDNA binding, reduced
crosslinking to primer template junctions but no pheno-
type. In contrast, mutant RPA2(MM1) had a higher aﬃn-
ity for DNA but also had the strongest DNA damage
phenotype. These data argue that RPA2–DNA interac-
tions are not essential for RPA function in cell viability
and growth.
The ‘hand-oﬀ’ model was originally proposed based on
analysis of protein interactions in SV40 DNA replication
(3). This model suggests that the winged helix of RPA2
recruits proteins and allows them to gain access to the
DNA by displacing DBD C and D from the DNA.
Although our ﬁndings do not rule out a role for the
winged-helix domain of RPA2 in protein recruiting, they
argue that interactions with DNA are not essential for
RPA2 function and indicate that the ‘hand-oﬀ’ model is
not occurring in yeast. This is not surprising as yeast cells
with a deletion of the winged helix survive and have no or
minimal phenotypes (31–33). Deletion of the winged helix
in yeast also only has a marginal eﬀect on the DNA
damage response (31,32).
If the DNA-binding activity of RPA2 is not essential,
what is the essential activity of this domain? At minimum,
RPA2 is necessary for the formation of the RPA complex
(9). In addition, a number of protein-interactions have
been mapped to RPA2 (3) indicating that DBD D could
also be participating in essential protein contacts. Other
DBDs in RPA, DBD A and DBD F in RPA1 also interact
with both proteins and DNA in their respective binding
clefts (16,17,49–51). In the case of RPA2, protein interac-
tions may be the predominant, critical function.
The model that RPA2 has an essential function in addi-
tion to complex formation is supported by analysis of
RPA in plants. The deepwater rice, Oryza satvia, has mul-
tiple genes encoding RPA1 and RPA2 subunits but only
one RPA3 gene. Three distinct forms of RPA are found in
O. satvia, each contains one of the RPA1 and RPA2 gene
products and all contain the common RPA3 subunit (52).
These three RPA complexes have diﬀerent expression and
intracellular localization patterns suggesting that they
have diﬀerent roles in the cell. Since these functionally
diﬀerent RPA complexes have diﬀerent RPA2 subunits
but share a single RPA3 subunit, it is most likely that
the RPA2 subunits have functions in addition to complex
formation. Multiple RPA genes and complexes also seem
to exist in Arabidopsis, where mutations in one gene for
Arabidopsis RPA1 are lethal but mutations in another
RPA1 gene only cause DNA damage sensitivity (53).
Humans also contain a second RPA2-related gene. This
RPA2-like subunit (called RPA4) is expressed in certain
human tissues and in some cell lines (54). RPA4 has 47%
identity with RPA2 and can form a complex with RPA1
and RPA3 (54). It is also interesting to note that RPA4
is reported to be predominantly expressed in quiescent
cells (54). This suggests that like plants, humans may
have diﬀerent RPA2/RPA4 in actively replicating versus
mature tissues. This also supports DBD D having func-
tions in non-complex related, tissue-speciﬁc functions.
Further studies are needed to deﬁne which protein inter-
actions are needed for RPA2 function.
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